Target Name: SCN10A
NCBI ID: G6336
Review Report on SCN10A Target / Biomarker Content of Review Report on SCN10A Target / Biomarker
SCN10A
Other Name(s): Sodium channel, voltage-gated, type X, alpha polypeptide | SCN10A variant 1 | sodium voltage-gated channel alpha subunit 10 | PN3 | peripheral nerve sodium channel 3 | SCN10A variant 2 | hPN3 | voltage-gated sodium channel subunit alpha Nav1.8 | Nav1.8 | Sodium channel protein type 10 subunit alpha (isoform 2) | sodium channel, voltage-gated, type X, alpha subunit | OTTHUMP00000045936 | SNS | Peripheral nerve sodium channel 3 | Sodium channel protein type 10 subunit alpha isoform 1 | FEPS2 | sodium channel protein type X subunit alpha | Sodium channel protein type X subunit alpha | SCNAA_HUMAN | Sodium channel protein type 10 subunit alpha | sodium channel, voltage-gated, type X, alpha polypeptide | Voltage-gated sodium channel subunit alpha Nav1.8 | Sodium voltage-gated channel alpha subunit 10, transcript variant 1 | SCN10A (Nav1.8) | sensory neuron sodium channel | Sodium voltage-gated channel alpha subunit 10, transcript variant 2 | SCNA10A

Sodium Channel alpha-helical protein: Research progress on drug targets (or biomarkers)

Summary

Sodium channel alpha-helical protein (SCN10A) is a sodium channel that plays a key role in physiological and pathological processes. It plays an important role in a variety of physiological processes, such as cell signaling, ion channel regulation, and nerve impulse transmission. At the same time, SCN10A is also considered a potential drug target in certain diseases, such as hypertension, cardiac arrhythmia, and kidney disease. This article aims to review the mechanism of action, biological significance of SCN10A and the latest progress in drug research, and provide useful enlightenment for related research.

1 Introduction

SCN10A is an 伪-helical protein that belongs to the sodium channel family. This protein is responsible for maintaining the influx of sodium ions on the cell membrane and is a key factor in nerve impulse transmission and cell signaling. The 伪-helical structure of SCN10A makes it highly specific, making it a hot target for drug research.

2. Mechanism of action of SCN10A

The main function of SCN10A is to promote the influx of sodium ions, thereby maintaining the concentration difference of sodium ions inside and outside the cell, and providing a stable resting potential for nerve impulse transmission and cell signaling. Specifically, SCN10A works by:

(1) 伪-helical structure

SCN10A has a high degree of 伪-helical structure, which makes the secondary structure of SCN10A highly symmetrical. This is beneficial to stabilizing the activity of SCN10A and reducing its binding force to substrates, thereby increasing the opening of its ion channels.

(2) Ion channel characteristics

SCN10A is an ion channel that mainly realizes the influx of sodium ions by opening sodium ion channels. In the resting state, the 伪-helical structure of SCN10A makes its ion channel highly selective and less permeable to other ions such as potassium and chloride ions. This makes SCN10A highly specific for sodium ion influx.

(3) Signal transduction

SCN10A plays an important role in signal transduction processes. Studies have shown that SCN10A can participate in signal transduction through the phosphorylation-level phosphorylation (phosphorylation-level phosphorylation) and tyrosine kinase (TK) pathways. Phosphorylation level Phosphorylation can increase the activity of SCN10A, thereby enhancing the opening of its ion channels. The TK pathway can regulate phosphorylation levels, thereby affecting the ion channel function of SCN10A.

3. Biological significance of SCN10A

SCN10A has important significance in cell biology. First of all, SCN10A is a key factor in maintaining the ion concentration difference between inside and outside cells, and plays a key role in maintaining normal physiological functions of cells. Secondly, SCN10A plays an important role in nerve impulse transmission. Research shows that SCN10A has multiple signal transduction pathways on neurons, such as calcium ion (Ca2+) signaling pathway, potassium ion (K+) signaling pathway, etc. In addition, SCN10A is also involved in biological processes such as apoptosis and cell cycle regulation.

4. Potential and challenges of SCN10A as a drug target

In recent years, with the deepening of ion channel research, people have found that SCN10A has potential drug target value in certain diseases. First, in patients with hypertension, the 伪-helical structure of SCN10A is considered to be a key factor leading to abnormal ion channels, so SCN10A may become a target for the treatment of hypertension. Secondly, SCN10A also has potential drug target value in cardiac arrhythmias. Studies have shown that the 伪-helical structure of SCN10A is closely related to the occurrence and development of arrhythmias, so SCN10A may become a target for the treatment of arrhythmias. In addition, the ion channel function of SCN10A may also play an important role in kidney disease. Therefore, regulating the ion channel function of SCN10A may provide new ideas for the treatment of kidney diseases.

However, SCN10A also faces some challenges as a drug target. First, the expression level of SCN10A in cells is low, which limits its application in drug research. Secondly, the ion channel function of SCN10A

Protein Name: Sodium Voltage-gated Channel Alpha Subunit 10

Functions: Tetrodotoxin-resistant channel that mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which sodium ions may pass in accordance with their electrochemical gradient. Plays a role in neuropathic pain mechanisms

The "SCN10A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCN10A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SCN11A | SCN1A | SCN1A-AS1 | SCN1B | SCN2A | SCN2B | SCN3A | SCN3B | SCN4A | SCN4B | SCN5A | SCN7A | SCN8A | SCN9A | SCNM1 | SCNN1A | SCNN1B | SCNN1D | SCNN1G | SCO1 | SCO2 | SCOC | SCOC-AS1 | SCP2 | SCP2D1 | SCP2D1-AS1 | SCPEP1 | SCRG1 | SCRIB | SCRN1 | SCRN2 | SCRN3 | SCRT1 | SCRT2 | SCT | SCTR | SCUBE1 | SCUBE2 | SCUBE3 | SCXA | SCYL1 | SCYL2 | SDAD1 | SDAD1-AS1 | SDAD1P1 | SDC1 | SDC2 | SDC3 | SDC4 | SDCBP | SDCBP2 | SDCBP2-AS1 | SDCBPP2 | SDCCAG8 | SDE2 | SDF2 | SDF2L1 | SDF4 | SDHA | SDHAF1 | SDHAF2 | SDHAF3 | SDHAF4 | SDHAP1 | SDHAP2 | SDHAP3 | SDHAP4 | SDHB | SDHC | SDHD | SDHDP1 | SDHDP2 | SDK1 | SDK1-AS1 | SDK2 | SDR16C5 | SDR16C6P | SDR39U1 | SDR42E1 | SDR42E2 | SDR9C7 | SDS | SDSL | SEBOX | SEC11A | SEC11B | SEC11C | SEC13 | SEC14L1 | SEC14L1P1 | SEC14L2 | SEC14L3 | SEC14L4 | SEC14L5 | SEC14L6 | SEC16A | SEC16B | SEC1P | SEC22A | SEC22B